Phytoglycogen-dsRNA nanoparticles demonstrate differential cytotoxicity and immunostimulatory potential in two ovarian cancer cell lines
Bibliographic record
Abstract
No abstract is available for this record. The assistant can identify its topic from the title, but cannot infer the study’s results.
Source: Not provided · Quality: missing
Research context
OpenAlex topics: RNA Interference and Gene Delivery · RNA and protein synthesis mechanisms · Plant and Fungal Interactions Research
SciVX discovery tags are terminology-based. OpenAlex topics are source-provided classifications.
References (41)
Show source-provided references
1. Coburn SB, Bray F, Sherman ME, Trabert B (2017) International patterns and trends in ovarian cancer incidence, overall and by histologic subtype. Int J Cancer 140(11):2451–2460. https://doi.org/10.1002/ijc.3067610.1002/ijc.30676 ↗
2. Chandra A, Pius C, Nabeel M, Nair M, Vishwanatha JK, Ahmad S, Basha R (2019) Ovarian cancer: current status and strategies for improving therapeutic outcomes. Cancer Med 8(16):7018–7031. https://doi.org/10.1002/cam4.256010.1002/cam4.2560 ↗
3. Bast RC, Hennessy B, Mills GB (2009) The biology of ovarian cancer: new opportunities for translation. Nat Rev Cancer 9(6):415–428. https://doi.org/10.1038/nrc264410.1038/nrc2644 ↗
4. Lengyel E (2010) Ovarian cancer development and metastasis. Am J Pathol 177(3):1053–1064. https://doi.org/10.2353/ajpath.2010.10010510.2353/ajpath.2010.100105 ↗
5. Salaun B, Coste I, Rissoan MC, Lebecque SJ, Renno T (2006) TLR3 can directly trigger apoptosis in human cancer cells. J Immunol 176(8):4894–4901. https://doi.org/10.4049/jimmunol.176.8.489410.4049/jimmunol.176.8.4894 ↗
6. Van DN, Roberts CF, Marion JD, Lépine S, Harikumar KB, Schreiter J, Dumur CI, Fang Z, Spiegel S, Bell JK (2012) Innate immune agonist, dsRNA, induces apoptosis in ovarian cancer cells and enhances the potency of cytotoxic chemotherapeutics. FASEB J 26(8):3188–3198. https://doi.org/10.1096/fj.11-20233310.1096/fj.11-202333 ↗
7. Bianchi F, Pretto S, Tagliabue E, Balsari A, Sfondrini L (2017) Exploiting poly (I: C) to induce cancer cell apoptosis. Cancer Biol Ther 18(10):747–756. https://doi.org/10.1080/15384047.2017.137322010.1080/15384047.2017.1373220 ↗
8. Ammi R, De Waele J, Willemen Y, Van Brussel I, Schrijvers DM, Lion E, Smits EL (2015) Poly (I: C) as cancer vaccine adjuvant: knocking on the door of medical breakthroughs. Pharmacol Ther 146:120–131. https://doi.org/10.1016/j.pharmthera.2014.09.01010.1016/j.pharmthera.2014.09.010 ↗
9. Palchetti S, Starace D, De Cesaris P, Filippini A, Ziparo E, Riccioli A (2015) Transfected poly (I: C) activates different dsRNA receptors, leading to apoptosis or immunoadjuvant response in androgen-independent prostate cancer cells. J Biol Chem 290(9):5470–5483. https://doi.org/10.1074/jbc.M114.60162510.1074/jbc.M114.601625 ↗
10. Nguyen TA, Smith BR, Tate MD, Belz GT, Barrios MH, Elgass KD, Weisman AS, Baker PJ, Preston SP, Whitehead L, Garnham A (2017) SIDT2 transports extracellular dsRNA into the cytoplasm for innate immune recognition. Immunity. 47(3):498–509. https://doi.org/10.1016/j.immuni.2017.08.00710.1016/j.immuni.2017.08.007 ↗
11. DeWitte-Orr SJ, Collins SE, Bauer CM, Bowdish DM, Mossman KL (2010) An accessory to the ‘Trinity’: SR-As are essential pathogen sensors of extracellular dsRNA, mediating entry and leading to subsequent type I IFN responses. PLoS Pathog 6(3):e1000829. https://doi.org/10.1371/journal.ppat.100082910.1371/journal.ppat.1000829 ↗
12. Hasselmann DO, Rappl G, Tilgen W, Reinhold U (2001) Extracellular tyrosinase mRNA within apoptotic bodies is protected from degradation in human serum. Clin Chem 47(8):1488–1489. https://doi.org/10.1093/clinchem/47.8.148810.1093/clinchem/47.8.1488 ↗
13. Ultimo A, Giménez C, Bartovsky P, Aznar E, Sancenón F, Marcos MD, Amoros P, Bernardo AR, Martinez-Manez R, Jimenez-Lara AM, Murguia JR (2016) Targeting innate immunity with dsRNA-conjugated mesoporous silica nanoparticles promotes antitumor effects on breast cancer cells. Chemistry 22(5):1582–1586. https://doi.org/10.1002/chem.20150462910.1002/chem.201504629 ↗
14. Elhaj Baddar Z, Gurusamy D, Laisney J, Tripathi P, Palli SR, Unrine JM (2020) Polymer-coated hydroxyapatite nanocarrier for double-stranded RNA delivery. J Agric Food Chem 68(25):6811–6818. https://doi.org/10.1021/acs.jafc.0c0218210.1021/acs.jafc.0c02182 ↗
15. Qu J, Hou Z, Han Q, Zhang C, Tian Z, Zhang J (2013) Poly (I:C) exhibits an anti-cancer effect in human gastric adenocarcinoma cells which is dependent on RLRs. Int Immunopharmacol 17(3):814–820. https://doi.org/10.1016/j.intimp.2013.08.01310.1016/j.intimp.2013.08.013 ↗
16. Massich MD, Giljohann DA, Schmucker AL, Patel PC, Mirkin CA (2010) Cellular response of polyvalent oligonucleotide− gold nanoparticle conjugates. ACS Nano 4(10):5641–5646. https://doi.org/10.1021/nn102228s10.1021/nn102228s ↗
17. Komal A, Noreen M, El-Kott AF (2021) TLR3 agonists: RGC100, ARNAX, and poly-IC: A comparative review. Immunol Res 69(4):312–322. https://doi.org/10.1007/s12026-021-09203-610.1007/s12026-021-09203-6 ↗
18. Le Naour J, Galluzzi L, Zitvogel L, Kroemer G, Vacchelli E (2020) Trial watch: TLR3 agonists in cancer therapy. Oncoimmunol 9(1):1771143. https://doi.org/10.1080/2162402X.2020.177114310.1080/2162402X.2020.1771143 ↗
19. Deci MB, Liu M, Dinh QT, Nguyen J (2018) Precision engineering of targeted nanocarriers. Wiley Interdiscip Rev Nanomed Nanobiotechnol 10(5):e1511. https://doi.org/10.1002/wnan.151110.1002/wnan.1511 ↗
20. Nickels JD, Atkinson J, Papp-Szabo E, Stanley C, Diallo SO, Perticaroli S, Baylis B, Mahon P, Ehlers G, Katsaras J, Dutcher JR (2016) Structure and hydration of highly-branched, monodisperse phytoglycogen nanoparticles. Biomacromolecules 17(3):735–743. https://doi.org/10.1021/acs.biomac.5b0139310.1021/acs.biomac.5b01393 ↗
21. Lewinski N, Colvin V, Drezek R (2008) Cytotoxicity of nanoparticles. Small 4(1):26–49. https://doi.org/10.1002/smll.20070059510.1002/smll.200700595 ↗
22. Alkie TN, de Jong J, Jenik K, Klinger KM, DeWitte-Orr SJ (2019) Enhancing innate antiviral immune responses in rainbow trout by double-stranded RNA delivered with cationic phytoglycogen nanoparticles. Sci Rep 9(1). https://doi.org/10.1038/s41598-019-49931-210.1038/s41598-019-49931-2 ↗
23. Semple SL, Alkie TN, Jenik K, Warner BM, Tailor N, Kobasa D, DeWitte-Orr SJ (2022) More tools for our toolkit: the application of HEL-299 cells and dsRNA-nanoparticles to study human coronaviruses in vitro. Virus Res 321:198925. https://doi.org/10.1016/j.virusres.2022.19892510.1016/j.virusres.2022.198925 ↗
24. NCBI. Poly I:C. National Library of Medicine. n.d. (accessed 2022-07-19)
25. Besford QA, Cavalieri F, Caruso F (2019) Glycogen as a building block for advanced biological materials. Adv Mater 32(18). https://doi.org/10.1016/j.carbpol.2021.11904110.1016/j.carbpol.2021.119041 ↗
26. Lu C, Li Z, Chang L, Dong Z, Guo P, Shen G, Xia Q, Zhao P (2019) Efficient delivery of dsRNA and DNA in cultured silkworm cells for gene function analysis using PAMAM dendrimers system. Insects 11(1):12. https://doi.org/10.3390/insects1101001210.3390/insects11010012 ↗
27. Khodadust R, Mutlu P, Yalcın S, Unsoy G, Gunduz U (2013) Polyinosinic: polycytidylic acid loading onto different generations of PAMAM dendrimer-coated magnetic nanoparticles. J Nanopart Res 15(8):1–12. https://doi.org/10.1007/s11051-013-1860-610.1007/s11051-013-1860-6 ↗
28. Zhao J, Zhang Z, Xue Y, Wang G, Cheng Y, Pan Y, Zhao S, Hou Y (2018) Anti-tumor macrophages activated by ferumoxytol combined or surface-functionalized with the TLR3 agonist poly (I: C) promote melanoma regression. Theranostics 8(22):6307. https://doi.org/10.7150/thno.2974610.7150/thno.29746 ↗
29. Nguyen TA, Whitehead L, Pang KC (2018) Quantification of extracellular double-stranded RNA uptake and subcellular localization using flow cytometry and confocal microscopy. Bio Protoc 8(12). https://doi.org/10.21769/BioProtoc.289010.21769/BioProtoc.2890 ↗
30. Karin N, Razon H (2018) Chemokines beyond chemo-attraction: CXCL10 and its significant role in cancer and autoimmunity. Cytokine 109:24–28. https://doi.org/10.1016/j.cyto.2018.02.01210.1016/j.cyto.2018.02.012 ↗
31. Wendel M, Galani IE, Suri-Payer E, Cerwenka A (2008) Natural killer cell accumulation in tumors is dependent on IFN-gamma and CXCR3 ligands. Cancer Res 68(20):8437–8445. https://doi.org/10.1158/0008-5472.CAN-08-144010.1158/0008-5472.CAN-08-1440 ↗
32. Liu M, Guo S, Stiles JK (2011) The emerging role of CXCL10 in cancer. Oncol Lett 2(4):583–589. https://doi.org/10.3892/ol.2011.30010.3892/ol.2011.300 ↗
33. Sui Y, Potula R, Dhillon N, Pinson D, Li S, Nath A, Anderson C, Turchan J, Kolson D, Narayan O, Buch S (2004) Neuronal apoptosis is mediated by CXCL10 overexpression in simian human immunodeficiency virus encephalitis. Am J Pathol 164(5):1557–1566. https://doi.org/10.1016/S0002-9440(10)63714-510.1016/S0002-9440(10)63714-5 ↗
34. Kübler K, Tho Pesch C, Gehrke N, Riemann S, Daßler J, Coch C, Landsberg J, Wimmenauer V, Pölcher M, Rudlowski C, Tüting T (2011) Immunogenic cell death of human ovarian cancer cells induced by cytosolic poly (I: C) leads to myeloid cell maturation and activates NK cells. E J Immuno l41(10):3028–3039. https://doi.org/10.1002/eji.20114155510.1002/eji.201141555 ↗
35. Riss TL, O’Brien MA, Moravec RA, Kupcho K, Niles AL (2021) Apoptosis marker assays for HTS. In: Assay guidance manual. National Center for Biotechnology Information
36. Kavanagh E, Rodhe J, Burguillos MA, Venero JL, Joseph B (2014) Regulation of caspase-3 processing by cIAP2 controls the switch between pro-inflammatory activation and cell death in microglia. Cell Death Dis 5(12):e1565-e. https://doi.org/10.1038/cddis.2014.51410.1038/cddis.2014.514 ↗
37. Deveraux QL, Roy N, Stennicke HR, Van Arsdale T, Zhou Q, Srinivasula SM, Alnemri ES, Salvesen GS, Reed JC (1998) IAPs block apoptotic events induced by caspase-8 and cytochrome c by direct inhibition of distinct caspases. EMBO J 17:2215–2223. https://doi.org/10.1093/emboj/17.8.221510.1093/emboj/17.8.2215 ↗
38. Huang HK, Joazeiro CA, Bonfoco E, Kamada S, Leverson JD, Hunter T (2000) The inhibitor of apoptosis, cIAP2, functions as a ubiquitin-protein ligase and promotes in vitro monoubiquitination of caspases 3 and 7. J Biol Chem 275(35):26661–26664. https://doi.org/10.1074/jbc.C00019920010.1074/jbc.C000199200 ↗
39. Sun X, Liu H (2020) Nucleic acid nanostructure assisted immune modulation. ACS Appl Bio Mater 3(5):2765–2778. https://doi.org/10.1021/acsabm.9b0119510.1021/acsabm.9b01195 ↗
40. Boyd MR, Paull KD (1995) Some practical considerations and applications of the National Cancer Institute in vitro anticancer drug discovery screen. Drug Dev Res 34:91–109. https://doi.org/10.1002/ddr.43034020310.1002/ddr.430340203 ↗
41. Poynter SJ, DeWitte-Orr SJ (2017) Visualizing virus-derived dsRNA using antibody-independent and-dependent methods. In: Innate Antiviral Immunity 103-118. Humana Press, New York, NY. https://doi.org/10.1007/978-1-4939-7237-1_510.1007/978-1-4939-7237-1_5 ↗